| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 阿咖酚散(元) | 4,972,344.06 | 7,875,594.30 | 4,265,936.12 |
| 胞磷胆碱钠片(元) | 148,284,223.65 | 335,286,988.32 | 161,152,205.91 |
| 苯甲酸利扎曲普坦胶囊(元) | 7,236,564.80 | 8,948,770.71 | 3,846,549.89 |
| 东方胃药胶囊(元) | 4,644,128.86 | 9,659,144.91 | 5,422,784.89 |
| 酚氨咖敏片(元) | - | - | 3,133,206.21 |
| 普瑞巴林口服溶液(元) | 1,369,714.94 | 6,976,612.83 | 3,256,876.45 |
| 塞来昔布胶囊(元) | 10,281,818.67 | 15,004,519.03 | 6,421,089.60 |
| 磷酸奥司他韦胶囊(元) | 7,505,686.45 | 3,432,427.72 | - |
| 清肠通便胶囊(元) | 1,782,302.63 | 4,568,250.60 | - |
| 玄驹胶囊(元) | - | 6,639,799.23 | - |
| 人工牛黄(元) | 3,434,955.73 | - | - |
| 其他品种(元) | 6,093,618.13 | 15,064,429.19 | 11,304,738.51 |
| 营业成本(元) | |||
| 阿咖酚散(元) | 3,389,246.11 | 5,492,608.13 | 2,982,170.97 |
| 胞磷胆碱钠片(元) | 17,018,162.40 | 39,760,554.68 | 18,760,872.75 |
| 苯甲酸利扎曲普坦胶囊(元) | 468,043.48 | 1,662,400.53 | 262,008.49 |
| 东方胃药胶囊(元) | 1,422,754.28 | 2,950,002.76 | 1,575,882.72 |
| 酚氨咖敏片(元) | - | - | 2,224,403.11 |
| 普瑞巴林口服溶液(元) | 696,643.56 | 1,746,155.94 | 552,026.84 |
| 塞来昔布胶囊(元) | 5,676,972.75 | 10,226,808.04 | 4,426,163.16 |
| 磷酸奥司他韦胶囊(元) | 5,894,973.74 | 2,642,738.10 | - |
| 清肠通便胶囊(元) | 845,988.25 | 2,022,188.61 | - |
| 玄驹胶囊(元) | - | 3,343,239.20 | - |
| 人工牛黄(元) | 2,944,288.96 | - | - |
| 其他品种(元) | 5,922,709.21 | 12,630,144.86 | 8,631,565.22 |
| 毛利(元) | |||
| 阿咖酚散(元) | 1,583,097.95 | 2,382,986.17 | 1,283,765.15 |
| 胞磷胆碱钠片(元) | 131,266,061.25 | 295,526,433.64 | 142,391,333.16 |
| 苯甲酸利扎曲普坦胶囊(元) | 6,768,521.32 | 7,286,370.18 | 3,584,541.40 |
| 东方胃药胶囊(元) | 3,221,374.58 | 6,709,142.15 | 3,846,902.17 |
| 酚氨咖敏片(元) | - | - | 908,803.10 |
| 普瑞巴林口服溶液(元) | 673,071.38 | 5,230,456.89 | 2,704,849.61 |
| 塞来昔布胶囊(元) | 4,604,845.92 | 4,777,710.99 | 1,994,926.44 |
| 磷酸奥司他韦胶囊(元) | 1,610,712.71 | 789,689.62 | - |
| 清肠通便胶囊(元) | 936,314.38 | 2,546,061.99 | - |
| 玄驹胶囊(元) | - | 3,296,560.03 | - |
| 人工牛黄(元) | 490,666.77 | - | - |
| 其他品种(元) | 170,908.92 | 2,434,284.33 | 2,673,173.29 |
| 毛利率(%) | |||
| 阿咖酚散(%) | 31.84 | 30.26 | 30.09 |
| 胞磷胆碱钠片(%) | 88.52 | 88.14 | 88.36 |
| 苯甲酸利扎曲普坦胶囊(%) | 93.53 | 81.42 | 93.19 |
| 东方胃药胶囊(%) | 69.36 | 69.46 | 70.94 |
| 酚氨咖敏片(%) | - | - | 29.01 |
| 普瑞巴林口服溶液(%) | 49.14 | 74.97 | 83.05 |
| 塞来昔布胶囊(%) | 44.79 | 31.84 | 31.07 |
| 磷酸奥司他韦胶囊(%) | 21.46 | 23.01 | - |
| 清肠通便胶囊(%) | 52.53 | 55.73 | - |
| 玄驹胶囊(%) | - | 49.65 | - |
| 人工牛黄(%) | 14.28 | - | - |
| 其他品种(%) | 2.80 | 16.16 | 23.65 |
| 收入构成(%) | |||
| 阿咖酚散(%) | 2.54 | 1.90 | 2.15 |
| 胞磷胆碱钠片(%) | 75.81 | 81.09 | 81.06 |
| 苯甲酸利扎曲普坦胶囊(%) | 3.70 | 2.16 | 1.93 |
| 东方胃药胶囊(%) | 2.37 | 2.34 | 2.73 |
| 酚氨咖敏片(%) | - | - | 1.58 |
| 普瑞巴林口服溶液(%) | 0.70 | 1.69 | 1.64 |
| 塞来昔布胶囊(%) | 5.26 | 3.63 | 3.23 |
| 磷酸奥司他韦胶囊(%) | 3.84 | 0.83 | - |
| 清肠通便胶囊(%) | 0.91 | 1.10 | - |
| 玄驹胶囊(%) | - | 1.61 | - |
| 人工牛黄(%) | 1.76 | - | - |
| 其他品种(%) | 3.12 | 3.64 | 5.69 |
| 毛利构成(%) | |||
| 阿咖酚散(%) | 1.05 | 0.72 | 0.81 |
| 胞磷胆碱钠片(%) | 86.74 | 89.29 | 89.34 |
| 苯甲酸利扎曲普坦胶囊(%) | 4.47 | 2.20 | 2.25 |
| 东方胃药胶囊(%) | 2.13 | 2.03 | 2.41 |
| 酚氨咖敏片(%) | - | - | 0.57 |
| 普瑞巴林口服溶液(%) | 0.44 | 1.58 | 1.70 |
| 塞来昔布胶囊(%) | 3.04 | 1.44 | 1.25 |
| 磷酸奥司他韦胶囊(%) | 1.06 | 0.24 | - |
| 清肠通便胶囊(%) | 0.62 | 0.77 | - |
| 玄驹胶囊(%) | - | 1.00 | - |
| 人工牛黄(%) | 0.32 | - | - |
| 其他品种(%) | 0.11 | 0.74 | 1.68 |